A Phase III, radonmized, double-blinded, parallel group, multi centre study to access the efficacy and safety of ZD6474 (ZACTIMA TM) in combination with pemetrexed (Alimta) versus pemetrexed alone in patients with locally-advanced or metastatic (stage IIIB or IV) non-small cell lung cancer (NSCLC) after failure of 1st line anti-cancer therapy


Grant Data
Project Title
A Phase III, radonmized, double-blinded, parallel group, multi centre study to access the efficacy and safety of ZD6474 (ZACTIMA TM) in combination with pemetrexed (Alimta) versus pemetrexed alone in patients with locally-advanced or metastatic (stage IIIB or IV) non-small cell lung cancer (NSCLC) after failure of 1st line anti-cancer therapy
Principal Investigator
Dr Ho, James Chung Man   (Principal investigator)
Co-Investigator(s)
Dr Wang Julie Kwan Ling   (Co-Investigator)
Dr Lam David Chi Leung   (Co-Investigator)
Dr Wong King Yan Matthew   (Co-Investigator)
Duration
31
Start Date
2007-02-01
Completion Date
2009-08-31
Amount
337838
Conference Title
Presentation Title
Keywords
locally-advanced, metastatic (stage IIIB or IV) NSCLC
Discipline
Respiration,Cancer
Panel
Medicine
Grant Type
Pharmaceutical Industry - General Award
Funding Year
2006/2007
Status
On-going